Your browser doesn't support javascript.
loading
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
Landgren, Ola; Weisel, Katja; Rosinol, Laura; Touzeau, Cyrille; Turgut, Mehmet; Hajek, Roman; Mollee, Peter; Kim, Jin Seok; Shu, Natalie; Hu, Xuguang; Li, Chuang; Usmani, Saad Z.
Afiliação
  • Landgren O; Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Weisel K; Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
  • Rosinol L; Hospital Clínic, IDIBAPS, Barcelona, Spain.
  • Touzeau C; Service d'hématologie Clinique, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Turgut M; Department of Internal Medicine, Division of Hematology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.
  • Hajek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Mollee P; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Kim JS; Department of Haematology, Princess Alexandra Hospital and University of Queensland Medical School, Brisbane, QLD, Australia.
  • Shu N; Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of South Korea.
  • Hu X; Parexel, Chengdu, China.
  • Li C; Amgen Inc., Thousand Oaks, California, USA.
  • Usmani SZ; Amgen Inc., Thousand Oaks, California, USA.
Br J Haematol ; 198(6): 988-993, 2022 09.
Article em En | MEDLINE | ID: mdl-35608261
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos